Improvements of Procedural Results With a New‐Generation Self‐Expanding Transfemoral Aortic Valve Prosthesis in Comparison to the Old‐Generation Device
- 24 November 2016
- journal article
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 30 (1) , 72-78
Abstract
Objectives: In this study, we compare procedural results of our first Evolut R (Medtronic, Minneapolis, MN, USA) implantations with the last CoreValve implantations. Main endpoints include paravalvular regurgitation, major vascular complications, stroke, and pacemaker implantation.Background: The evolution of transcatheter aortic valve replacement (TAVR) was possible due to various technical improvements, leading to better periprocedural and long‐term outcome. The newly designed Evolut R valve has the potential to further improve TAVR's performance.Methods: We retrospectively analyzed our first 100 consecutive patients who received the Evolut R valve with the last 100 consecutive patients who received the CoreValve prosthesis between July 2013 and February 2016. Only patients treated with a 26 mm or 29 mm bioprosthesis were included.Results: No significant differences in patient characteristics were noticed. Both angiography and echocardiography after TAVR showed significantly higher rates of “none or trace” regurgitation in the Evolut R group (angiography: 67% Evolut R vs. 29.3% CoreValve; P < 0.001; echocardiography: 68% Evolut R vs. 46.5% CoreValve; P < 0.05). No significant differences were seen in 30‐day mortality (7% CoreValve vs. 1% Evolut R), stroke rates (3% CoreValve vs. 2% Evolut R), pacemaker implantation rates (24% CoreValve vs. 23% Evolut R), and major vascular complications (6% CoreValve vs. 1% Evolut R). Implantations were significantly higher with the Evolut R prosthesis.Conclusions: TAVR with the new Evolut R resulted in significantly lower paravalvular regurgitation. This may be due to redesigned cell geometry and higher precision during implantations, as well as the ability to resheath a malpositioned valve.Keywords
This publication has 15 references indexed in Scilit:
- Patient selection for TAVI 2015 - TAVI in low-risk patients: fact or fiction?EuroIntervention, 2015
- Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve ReplacementsJACC, 2015
- Transcatheter Aortic Valve Replacement Using a Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at Extreme Risk for SurgeryJACC, 2014
- First-in-human experience with the Medtronic CoreValve Evolut REuroIntervention, 2014
- Impact of Post-Procedural Aortic Regurgitation on Mortality After Transcatheter Aortic Valve ImplantationJACC: Cardiovascular Interventions, 2012
- Guidelines on the management of valvular heart disease (version 2012)European Heart Journal, 2012
- Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk PatientsNew England Journal of Medicine, 2011
- Permanent Pacemaker Insertion After CoreValve Transcatheter Aortic Valve ImplantationCirculation, 2011
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryNew England Journal of Medicine, 2010
- 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart DiseaseJACC, 2008